These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 492482)

  • 1. The importance of serotonergic mechanisms for the induction of hyperactivity by amphetamine and its antagonism by intra-accumbens (3,4-dihydroxy-phenylamino)-2-imidazoline (DPI).
    Costall B; Hui SC; Naylor RJ
    Neuropharmacology; 1979 Jul; 18(7):605-9. PubMed ID: 492482
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of amphetamine hyperactivity by DPI injected into rat nucleus accumbens [proceedings].
    Costall B; Hui SC; Naylor RJ
    Br J Pharmacol; 1978 Nov; 64(3):461P. PubMed ID: 719302
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential effects of (3,4-dihydroxyphenylamino)-2-imidazoline (DPI) on hyperactivity responses to dopamine agonists injected in the nucleus accumbens.
    Costall B; Hui SC; Naylor RJ
    J Pharm Pharmacol; 1979 Jul; 31(7):478-80. PubMed ID: 38322
    [No Abstract]   [Full Text] [Related]  

  • 4. LSD mescaline and serotonin injected into medial raphe nucleus potentiate apomorphine hypermotility.
    Fink H; Oelssner W
    Eur J Pharmacol; 1981 Nov; 75(4):289-96. PubMed ID: 7318915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic interaction with the serotoninergic-dopaminergic mechanisms in the nucleus accumbens.
    Costall B; Naylor RJ
    J Pharm Pharmacol; 1978 Apr; 30(4):257-9. PubMed ID: 24720
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of serotonergic agonists in the nucleus accumbens on d-amphetamine-stimulated locomotion.
    Layer RT; Uretsky NJ; Wallace LJ
    Life Sci; 1992; 50(11):813-20. PubMed ID: 1740965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of dopamine in the anorexigenic effect of DITA; comparison with d-amphetamine.
    Abdallah AH; Roby DM; Boeckler WH; Riley CC
    Eur J Pharmacol; 1976 Nov; 40(1):39-44. PubMed ID: 991928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of antiserotonergic agents on the action of dopaminergic drugs.
    Mogilnicka E; Scheel-Krüger J; Klimek V; Golembiowska-Nikitin K
    Pol J Pharmacol Pharm; 1977; 29(1):31-8. PubMed ID: 140371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence against serotonin involvement in the hyperactivity produced by injections of muscimol into the median raphe nucleus.
    Wirtshafter D; Klitenick MA; Asin KE
    Pharmacol Biochem Behav; 1987 May; 27(1):45-52. PubMed ID: 2441421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral function of GABA in the median raphe nucleus.
    Fink H; Morgenstern R
    Biomed Biochim Acta; 1986; 45(4):531-8. PubMed ID: 3707566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collateral inhibition of serotonergic neurones in the rat dorsal raphe nucleus: pharmacological evidence.
    Wang RY; Aghajanian GK
    Neuropharmacology; 1978 Oct; 17(10):819-25. PubMed ID: 154620
    [No Abstract]   [Full Text] [Related]  

  • 12. Dorsal raphe neurons: self-inhibition by an amphetamine-induced release of endogenous serotonin.
    Rebec GV; Curtis SD; Zimmerman KS
    Brain Res; 1982 Nov; 251(2):374-9. PubMed ID: 7139334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine.
    Heffner TG; Seiden LS
    Brain Res; 1982 Jul; 244(1):81-90. PubMed ID: 6288184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional localization of the antagonism of amphetamine-induced hyperactivity by intracerebral calcitonin injections.
    de Beaurepaire R; Freed WJ
    Pharmacol Biochem Behav; 1987 May; 27(1):183-6. PubMed ID: 3615541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible mechanism of 5-methoxy-N,N-dimethyltryptamine-induced turning behaviour in DRN lesioned rats.
    Blackburn TP; Cox B; Heapy CG; Lee TF
    Pharmacol Biochem Behav; 1982 Jan; 16(1):7-11. PubMed ID: 7058215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of putative 5-hydroxytryptamine receptor active agents on D-amphetamine self-administration in controls and rats with 5,7-dihydroxytryptamine median forebrain bundle lesions.
    Leccese AP; Lyness WH
    Brain Res; 1984 Jun; 303(1):153-62. PubMed ID: 6610461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of serotonin 2A receptors in the D-amphetamine-induced release of dopamine: comparison with previous data on alpha1b-adrenergic receptors.
    Auclair A; Blanc G; Glowinski J; Tassin JP
    J Neurochem; 2004 Oct; 91(2):318-26. PubMed ID: 15447665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleus accumbens lesions reduce amphetamine hyperthermia but not hyperactivity.
    Wirtshafter D; Asin KE; Kent EW
    Eur J Pharmacol; 1978 Oct; 51(4):449-52. PubMed ID: 710513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of serotonergic and cholinergic systems in the aggression-stereotypy complex produced by amphetamine in mice.
    Roliński Z
    Pol J Pharmacol Pharm; 1977; 29(6):591-602. PubMed ID: 304574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic antagonism of the motor inhibitory effects of apomorphine within the nucleus accumbens: drug interaction at presynaptic receptors?
    Costall B; Fortune DH; Hui SC; Naylor RJ
    Eur J Pharmacol; 1980 May; 63(4):347-58. PubMed ID: 6104603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.